Overview

Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery

Status:
Terminated
Trial end date:
2019-08-30
Target enrollment:
Participant gender:
Summary
This is a randomized controlled pilot study evaluating length of pain control with either liposomal bupivacaine or with bupivacaine plus decadron after PEC II injection in patients having bilateral mastectomies with immediate reconstruction.
Phase:
Phase 4
Details
Lead Sponsor:
Prisma Health-Upstate
Treatments:
Bupivacaine